Pentwater Capital Management LP Bicycle Therapeutics PLC Transaction History

Pentwater Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$12.95 - $46.99 $181,300 - $657,860	-14,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$40.12 - $59.5 $1.02 Million - $1.52 Million	-25,500 Reduced 64.56%	14,000 $614,000
Q4 2021 Feb 11, 2022	BUY	$41.7 - $61.14 $1.15 Million - $1.68 Million	27,500 Added 229.17%	39,500 $2.4 Million
Q3 2020 Nov 16, 2020	SELL	$15.3 - $20.8 $7,650 - $10,400	-500 Reduced 4.0%	12,000 $229,000
Q1 2020 May 15, 2020	SELL	$9.82 - $18.0 $393,654 - $721,566	-40,087 Reduced 76.23%	12,500 $171,000

Q4 2019 Feb 14, 2020	SELL	$7.68 - $11.08 $39,168 - $56,508	-5,100 Reduced 8.84%	52,587 $496,000
Q3 2019 Nov 14, 2019	SELL	$6.74 - $12.01 $41,349 - $73,681	-6,135 Reduced 9.61%	57,687 $657,000
Q2 2019 Aug 14, 2019	BUY	$10.06 - $14.63 $642,049 - $933,715	63,822 New	63,822 $642,000

30.6M

85.5K

11.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $600M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Pentwater Capital Management LP with notifications on news.